Key facts
- This page summarizes Andrew K. Balo's Form 4 filing for DEXCOM INC (DXCM).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2023, 16:45.
Andrew K. Balo - 10 Mar 2023 Form 4 Insider Report for DEXCOM INC (DXCM)
- Reporting relationship
- EVP Regulatory Strategy Clinic
- Issuer ticker
- DXCM
- Reported as of
- 10 Mar 2023
- Net transaction value
- -$1,300,026
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2023, 16:45:58 UTC
- Prior SEC filing
- 10 Mar 2022
- Next SEC filing
- 28 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- By: Jereme Sylvain For: Andrew K Balo
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew K. Balo filed Form 4 for DEXCOM INC (DXCM) on 14 Mar 2023.
Change
- Previous filing in this sequence was filed on 10 Mar 2022.
- Current net transaction value: -$1,300,026.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DXCM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $364,832
- Shares
- -3,275
- Change %
- -5.2%
- Price
- $111.40
- Shares after
- 59,303
- Date
- 10 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2
DXCM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $267,915
- Shares
- -2,405
- Change %
- -4.1%
- Price
- $111.40
- Shares after
- 56,898
- Date
- 10 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2
DXCM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $667,280
- Shares
- -5,990
- Change %
- -11%
- Price
- $111.40
- Shares after
- 50,908
- Date
- 10 Mar 2023
- Ownership
- Direct
- Footnotes
- F1, F2
DXCM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 30,212
- Date
- 10 Mar 2023
- Ownership
- by Trust
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Andrew K. Balo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Footnote F2
Included in this number are 20,356 unvested restricted stock units, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
Footnote F3
Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.